Abstract:Importance: Social and occupational impairments contribute to the burden of psychosis and depression. There is a need for risk stratification tools to inform personalized functional-disability preventive strategies for individuals in at-risk and early phases of these illnesses. Objective: To determine whether predictors associated with social and role functioning can be identified in patients in clinical high-risk (CHR) states for psychosis or with recent-onset depression (ROD) using clinical, imaging-based, and combined machine learning; assess the geographic, transdiagnostic, and prognostic generalizability of machine learning and compare it with human prognostication; and explore sequential prognosis encompassing clinical and combined machine learning. Design, setting, and participants: This multisite naturalistic study followed up patients in CHR states, with ROD, and with recent-onset psychosis, and healthy control participants for 18 months in 7 academic early-recognition services in 5 European countries. Participants were recruited between February 2014 and May 2016, and data were analyzed from April 2017 to January 2018. ain outcomes and measures: Performance and generalizability of prognostic models. Results: A total of 116 individuals in CHR states (mean [SD] age, 24.0 [5.1] years; 58 [50.0%] female) and 120 patients with ROD (mean [SD] age, 26.1 [6.1] years; 65 [54.2%] female) were followed up for a mean (SD) of 329 (142) days. Machine learning predicted the 1-year social-functioning outcomes with a balanced accuracy of 76.9% of patients in CHR states and 66.2% of patients with ROD using clinical baseline data. Balanced accuracy in models using structural neuroimaging was 76.2% in patients in CHR states and 65.0% in patients with ROD, and in combined models, it was 82.7% for CHR states and 70.3% for ROD. Lower functioning before study entry was a transdiagnostic predictor. Medial prefrontal and temporo-parieto-occipital gray matter volume (GMV) reductions and cerebellar and dorsolateral prefrontal GMV increments had predictive value in the CHR group; reduced mediotemporal and increased prefrontal-perisylvian GMV had predictive value in patients with ROD. Poor prognoses were associated with increased risk of psychotic, depressive, and anxiety disorders at follow-up in patients in the CHR state but not ones with ROD. Machine learning outperformed expert prognostication. Adding neuroimaging machine learning to clinical machine learning provided a 1.9-fold increase of prognostic certainty in uncertain cases of patients in CHR states, and a 10.5-fold increase of prognostic certainty for patients with ROD. Conclusions and relevance: Precision medicine tools could augment effective therapeutic strategies aiming at the prevention of social functioning impairments in patients with CHR states or with ROD.

Optimizing the Prediction of Depression Remission: A Longitudinal Machine Learning Approach

Using Machine Learning to Predict Antidepressant Treatment Outcome from Electronic Health Records

Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.

Reinforcement learning processes as forecasters of depression remission

Combining machine learning algorithms for prediction of antidepressant treatment response

Predicting remission after acute phase pharmacotherapy in patients with bipolar I depression: A machine learning approach with cross‐trial and cross‐drug replication

Machine Learning Prediction of Treatment Outcome in Late-Life Depression

Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis

Examining factors related to low performance of predicting remission in participants with major depressive disorder using neuroimaging data and other clinical features

Prediction of Antidepressant Treatment Response and Remission Using an Ensemble Machine Learning Framework

Cross-trial prediction of depression remission using problem-solving therapy: A machine learning approach

Optimizing precision medicine for second-step depression treatment: a machine learning approach

Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment

Predicting functional impairment in euthymic patients with mood disorder: A 5-year follow-up

Prediction and diagnosis of depression using machine learning with electronic health records data: a systematic review

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder

Predicting treatment outcome in depression: an introduction into current concepts and challenges

Machine learning applied to the prediction of relapse, hospitalization, and suicide in bipolar disorder using neuroimaging and clinical data: A systematic review

Individualized prediction of psychiatric readmissions for patients with major depressive disorder: a 10-year retrospective cohort study

Development and Validation of a Deep-Learning Model for Differential Treatment Benefit Prediction for Adults with Major Depressive Disorder Deployed in the Artificial Intelligence in Depression Medication Enhancement (AIDME) Study